Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Non-Small Cell Lung Cancer NSCLC × durvalumab × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 4 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Unresectable Hepatocellular Carcinoma 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcopenia 1 Recurrent Squamous Cell Lung Carcinoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oropharyngeal Neoplasms 1 Non-Small Cell Lung Cancer NSCLC 1 Neoplasms 1 Melanoma 1 Kidney Neoplasms 1 Hepatobiliary Cancers 1 Head and Neck Neoplasms 1 Deglutition Disorders 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04667312 2023-10-02

CODAK

AstraZeneca

Non-Small Cell Lung Cancer NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡